---
link: https://news.google.com/rss/articles/CBMib0FVX3lxTE1JV3M0Q2xhMEptek83ZTFUUmdzYWFZeVp1bG9uUHlqUk5BSDNucG40a3B4R0lyMjd1SlBQbWxJQW1JRG5TTkJRc0Flc2pTMnhKR0ZZbWZhUWRJcjUxWWF4ZjBONUN4QXNvc2Fxem1lOA?oc=5
author: 
published: Tue, 23 Dec 2025 02:52:00 GMT
tags: [News, Google, 경제]
---
# ‘먹는 위고비’ 미국서 승인…비만 치료제 중 가장 저렴한 149달러 - 한겨레

[원문 링크](https://news.google.com/rss/articles/CBMib0FVX3lxTE1JV3M0Q2xhMEptek83ZTFUUmdzYWFZeVp1bG9uUHlqUk5BSDNucG40a3B4R0lyMjd1SlBQbWxJQW1JRG5TTkJRc0Flc2pTMnhKR0ZZbWZhUWRJcjUxWWF4ZjBONUN4QXNvc2Fxem1lOA?oc=5)

## 요약/본문
<ol><li><a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1JV3M0Q2xhMEptek83ZTFUUmdzYWFZeVp1bG9uUHlqUk5BSDNucG40a3B4R0lyMjd1SlBQbWxJQW1JRG5TTkJRc0Flc2pTMnhKR0ZZbWZhUWRJcjUxWWF4ZjBONUN4QXNvc2Fxem1lOA?oc=5" target="_blank">‘먹는 위고비’ 미국서 승인…비만 치료제 중 가장 저렴한 149달러</a>&nbsp;&nbsp;<font color="#6f6f6f">한겨레</font></li><li><a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQckIzaVlFSkRPNWlaUk1PYVdmOEpNWk1ZYUdEcWtWak54NWQ3WkVCWFZlcEdpTGEzeHNUaHVjbG5rdk8wRVQ3NXNaekFFXzRjSEVLdlJvMHFYMkw0V01lSHJxcWlrSVpuZkk0X28wSTQ2b3Z4d1UwRlJWeUtDY2VSNnlyZ2g1QnfSAZsBQVVfeXFMTmZEVlM1ZHJueGt2NGNjOTQ5UlMtcU5yaUtERDl5dXZyX3FKWE9LdXNHY3gxSUFjRXpDeGxBNU1neC1nMWdsTWxFR2pQMUhyTGYtVjdqZzl3NFV0bnNXQ0RNSHpHYmt5a2R1U3ZfdlFBSFVFTEo1SkJaVG96bmtiQllPZS00OUtnS1lFcjhucElKRjZCWjVuenpxRHc?oc=5" target="_blank">노보 노디스크, ‘먹는 위고비’ 美 FDA 승인…세계 최초 GLP-1 비만약 - 조선비즈</a>&nbsp;&nbsp;<font color="#6f6f6f">Chosunbiz</font></li><li><a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFB6QmhVVXFBV0ZPRERZMS1qS2l2ekhKSVZ2RVA1VndyZ3gyLW81a2daZmU3QjhQZ3dpajdfXzJCOV95dFNkREtlb08tSU85RW52U0NUV2U2S2pURlV6V0HSAYMBQVVfeXFMUGp6U3hvd0FpcVJXOFVHems2bDhRZFFMeGNQWGFad1hLNnl0dk9rWGFsZHhKT1ZrakxaOTZMU2tCY0JUeU9JSkIxaU9tbk1UZE9PUVpzb2hPdTlla1BXOFBsR0paa19BdGlXSm15VkszVFowNXJNYXEzNlhjUzI4N0Y0V28?oc=5" target="_blank">비만약 '먹는 위고비' 시대 개막... 내년 1월 미국 출시 [지금이뉴스]</a>&nbsp;&nbsp;<font color="#6f6f6f">YTN</font></li><li><a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9zUlBTZVRxSWZ1N2NMaDdZTWNyU1VvYzhyaWk3MGxkcWJkTHFjMmZQcTZLTVZqZEE1TUpjZ2lHdFhXY0NMTUdfN192Yl82aGY5UnAxTQ?oc=5" target="_blank">"운동 왜 해?"...위고비 열풍에 헬스장·먹거리 산업 흔들</a>&nbsp;&nbsp;<font color="#6f6f6f">이투데이</font></li><li><a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9IeWZ1X1I4d1FDY3ZwY1hRd3dMWlN6RWF4czF5YnRtSHUxM0JwVy1GTWhBeFEyWG1TOWNOdHNrQ3RYRG5USFN6Ym1mNF9tdGxUTy1FbWZSX0lrTUtNRjVIZFpSdXLSAXhBVV95cUxNQjFYTWtiQkFXNWJKZkZvLTV3TUxjcjV6bmE5bzJ4WF90cnRIZnd5dWJGZkc2NmlxWWcxX0xDaDA4MlJFckVMY1JjSVlGSExPb1ZraW1JU0dwVURvNzhzSkx6cXdydmYxOFhtNGMtRDU5bFVNLUdaY1I?oc=5" target="_blank">美 FDA, 노보 '위고비' 알약 승인…비만 치료제 시장, 주사제서 알약으로</a>&nbsp;&nbsp;<font color="#6f6f6f">뉴시스</font></li></ol>
